Back to results list
Show full item record
Please use this identifier to cite or link to this item:
|Title:||Assessing the EORTC QLQ-BM22 module using rasch modeling and confirmatory factor analysis across countries : a comprehensive psychometric evaluation in patients with bone metastases||Authors:||Lin, CY
Confirmatory factor analysis
Quality of life
|Issue Date:||2016||Publisher:||Asian Pacific Organization for Cancer Prevention||Source:||Asian Pacific journal of cancer prevention, 2016, v. 17, no. 3, p. 1405-1410 How to cite?||Journal:||Asian Pacific journal of cancer prevention||Abstract:||Background: The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases Module (EORTC QLQ-BM22) is a recently designed supplement to EORTC Quality of Life Questionnaire-C30 (EORTC QLQ-C30). Additional psychometric properties, especially using confirmatory factor analysis (CFA) and the Rasch model, are warranted.
Materials and Methods: A total of 573 patients with bone metastases were enrolled from eight countries with a mean±SD age of 55.8±13.7 years. Slightly more than two thirds of them were female (n=383; 66.8%). CFA was used to examine the BM22 framework; Rasch models were applied to understand misfit items and differential item functioning (DIF).
Results: The fit indices were satisfactory in CFA (comparative fit index=0.972, Tucker-Lewis index=0.964, root mean square error of approximation=0.076, and standardized root mean square residual=0.045). All items fit well in the Rasch models (mean square values were between 0.5 and 1.5), and only one item (number 17) displayed DIF across gender. However, there were six DIF items across Canada and Taiwan, ten across Canada and Iran, and six across Taiwan and Iran.
Conclusions: The BM22 has satisfactory psychometric properties, and could assess the QoL of patients with bone metastases specifically focusing on their symptoms. Clinicians may want to use it to capture the underlying QoL for patients with bone metastases. However, the score of item 17 should be interpreted with caution when comparing male and female patients. In addition, researchers should note that variation in DIF items may occur when conducting an international study.
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Citations as of Dec 8, 2018
Citations as of Dec 10, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.